蛋白

重组人类肿瘤蛋白P53, 谷胱甘肽S-转移酶标签

TP53-1077H

重组人类肿瘤蛋白P53, 谷胱甘肽S-转移酶标签

Creative Biomart

TP53

肿瘤蛋白p53

TP53; tumor protein p53; P53; BCC7; LFS1; TRP53; cellular tumor antigen p53; antigen NY-CO-13; tumor protein 53; phosphoprotein p53; p53 tumor suppressor; mutant tumor protein 53; transformation-related protein 53;

Recombinant protein production has become an essential tool for providing the necessary amounts of a protein of interest to either research or therapy by providing adequate amounts of proteins for studying protein structure and function. Moreover, scaled-up facilities produce recombinant vaccines, hormones, antibodies, growth factors, blood components, and enzymes.

p53 was identified as a tumor suppressor by showing that this protein has the ability to block transformation and to inhibit tumor cell growth. In addition, p53 is a transcription factor capable of regulating the expression of a subset of downstream genes. Mutation of two specific N-terminal residues in p53 (residues Leu22 and Trp23) impairs the ability of p53 to transactivate and has been correlated with its ability to bind TAFII40 and TAFII60 (or TAFII31 and TAFII70) suggesting that one or both of these interactions is important for activation. Mutation of residues 22 and 23 to Ala does not affect binding to TBP, although mutation of these residues to charged amino acids has been reported to disrupt the p53-TBP interaction. Different mutations in p53 gene have been characterized in a variety of human cancers. Loss or mutation of p53 function is highly correlated with tumorigenesis. GST-p53 is isolated from a strain of E. coli that contains the coding sequence of wild type human p53 (amino acids 1-81) under the control of T7 promoter. The fusion protein is immunoreactive with the human p53 specific monoclonal antibody.

Ecoli

液体。 用品在20mM三羟甲基氨基甲烷氯化氢pH8.0, 20% 甘油, 100mM氯化钾, 0.2mM乙二胺四乙酸和1mM DTT

95% by SDS-PAGE.

Quality guaranteed for 12 months. Store at -80℃. Avoid freeze / thaw cycles.

P04637